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SllmmRry 
The adult liver is an organ without constitutive lymphoid components. Therefore, any intrahepatic 
T cell found in chronic hepatitis should have migrated to the liver after infection and inflammation. 
Because of the little information available on the differences between intrahepatic and peripheral 
T  cells, we used recombinant proteins of the hepatitis C  virus (HCV) to establish  specific T 
cell lines and clones from liver biopsies of patients with chronic hepatitis C and compared them 
with those present in peripheral blood mononuclear cells (PBMC). We found that the protein 
nonstructural 4 (NS4) was able to stimulate CD4 + T cells isolated from liver biopsies, whereas 
with all the other HCV proteins we consistently failed to establish liver-derived T cell lines from 
16 biopsies. We then compared NS4-specific T cell clones obtained on the same day from PBMC 
and liver of the same patient. We found that the 22 PBMC-derived T cell clones represent, at 
least, six distinct clonal populations that differ in major histocompatibility complex restriction 
and response to superantigens, whereas the 27 liver-derived  T  cell clones appear  all identical, 
as further confirmed by cloning and sequencing of the T  cell receptor (TCK)  variable  and 
hypervariable  regions. Remarkably, none of the PBMC-derived clones has a TCK identical to 
the liver-derived  clone, and even with polymerase chain reaction oligotyping we did not find 
the liver-derived clonotypic TCK transcript in the PBMC, indicating a preferential intrahepatic 
localization of these T cells. Functionally, the liver-derived T cells provided help for polyclonal 
immunoglobulin (Ig)A production by B cells in vitro that is 10-fold more effective than that 
provided by the PBMC-derived clones, whereas there is no difference in the help provided for 
IgM and IgG production. Altogether these results demonstrate that the protein Ng4 is highly 
immunogenic for intrahepatic CD4 + T  cells primed by HCV in vivo, and that there can he 
compartmentalization of some NS4-specific CD4 + T cells to the liver of patients with chronic 
hepatitis C. 
H 
epatitis C virus (HCV) 1 is an KNA virus responsible 
for the majority of blood-borne non-A, non-B hepa- 
titis (1), which induces chronic hepatitis in at least half the 
infected patients (2). At present, it is not known what role 
the immune response plays in the course of HCV infection. 
We have previously reported that PBMC from HCV-infected 
individuals proliferate in response to HCV recombinant pro- 
teins and that peripheral responses to the Core protein corre- 
late with a benign course of infection (3). However, the study 
1 Abbreviations used in thispaper: E, envelope; HCV, hepatitis C virus; HS, 
human serum; NS, nonstructural; SE, staphylococcal enterotoxin; SOD, 
superoxide dismutase. 
of T cell responses in the peripheral blood, although critical 
to the understanding of both the immunogenicity of viral 
proteins and the immune status of the individual, does not 
necessarily reflect the pattern of T cell responses present in 
the liver. Information on phenotype and function of intra- 
hepatic T  cells may be relevant to the understanding of the 
preferential presence, i.e., compartmentalization, of some T 
cells into the liver and can therefore help in elucidating the 
immunopathogenesis of chronic hepatitis C. Since the adult 
liver is an organ without constitutive lymphoid components 
(4), any intrahepatic T cell found in chronic hepatitis should 
have migrated to the liver after infection and inflammation. 
Once in the tissue, T cells can be restimulated by Ag to un- 
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functions, whether they are cytotoxic or delayed-type hyper- 
sensitivity (DTH)  responses.  Generally, CD4 + T  cells are 
critical to the accomplishment of any effector function of the 
immune system, since they can act both directly as DTH in- 
ducers (5) and may be killer cells (6), and indirectly helping 
both  B  lymphocytes to  produce  neutralizing Ab  (7)  and 
CD8 + T  cell precursors to mature to effector killer cells (8). 
We have studied the specificity and function of CD4 + T 
lymphocytes infiltrating the liver of patients with chronic 
hepatitis C. Using recombinant proteins of HCV, we estab- 
lished T  cell lines and clones from both liver biopsies and, 
when possible,  the corresponding PBMC.  To study T  cell 
compartmentalization,  CD4 + T  cell clones obtained from 
PBMC and liver of the same individual and specific for the 
same HCV protein were compared for MHC restriction, TCR 
reactivity to bacterial superantigens, lymphokine production, 
killing ability, and helper activity for Ig production by B cells 
in vitro. Here we show evidence that some nonstructural 4 
(NS4)-specific CD4 + T  cells, with a peculiar ability to help 
IgA production, can compartmentalize to the liver of patients 
with chronic hepatitis  C. 
Materials  and Methods 
Patients with Chronic Hepatitis C.  The three patients studied had 
HCV-specific serum antibodies, detected by two second-generation 
ELISAs (Abbott Laboratories,  North Chicago; and Ortho Diag- 
nostic Systems, Raritan, NJ), specific for the Core, NS3, and NS4 
proteins. Two patients (nos. 13 and 14) had ongoing chronic hepa- 
titis demonstrated by elevated serum levels (>40 U/liter) of ala- 
nine aminotransferase  (ALT) for >1 yr. No. 13 is a 61-yr-old fe- 
male with a histologic diagnosis of chronic active hepatitis,  and 
no. 14 is a 53-yr-old male with a histologic diagnosis of nonspecific 
reactive hepatitis. The third study subject is a patient (no. 71) whose 
chronic hepatitis C went into clinical remission upon IFN-c~ treat- 
ment, as demonstrated by the range values of serum ALT (i.e., 8-14 
U/liter) in 12 monthly tests and by the absence of symptoms of 
liver disease for 12 mo since IFN-a treatment. No. 71 is a 36-yr- 
old female with a histologic diagnosis  of fibrosis. 
HCV Recorabinant Proteins.  The HCV proteins Core, envelope 
1 (El), envelope 2 (E2), NS3--4, NS4, and NS5 were expressed as 
COOH-terminal fusions with human superoxide dismutase (SOD) 
in yeast ( Saccharomyces cerevisiae) using the method described ear- 
lier for the expression of the C100-3 HCV-Ag (1) and purified as 
previously reported (3). 
Cell Cultures.  Culture medium was RPMI 1640 (Gibco Labora- 
tories, Grand Island, NY) supplemented  with 2 mM L-glutamine, 
1% nonessential  amino acids, I mM sodium pyruvate,  100 U/ml 
penicillin, 100/~g/ml streptomycin, and 5% human serum (KPMI- 
HS).  For the growth of T  cell lines and clones,  RPMI-HS was 
supplemented with 50 U/ml rib2 (Cetus Corp., Emeryville, CA). 
Establishment of Liver-derived T Cell Lines.  Liver biopsies ('~2- 
cm length and 1.5-mm diameter), taken from patients who gave 
informed consent, were put in petri dishes with RPMI-HS and 
washed  vigorously with  a  Pasteur  pipette,  to  eliminate  con- 
taminating blood lymphocytes. They were manually homogenized 
in glass mortars (Bellco International, Feltham, UK) in the pres- 
ence of 5 ml RPMI-HS, and mononuclear cells were separated by 
Ficoll-Hypaque (Pharmacia, Uppsah, Sweden) density-gradient cen- 
trifugation, washed twice in RPMI-HS, and counted. Generally, 
we recovered 3-8  x  104 mononuclear cells/biopsy. Approximately 
6  x  103 liver-derived mononuclear cells were cultured with 103 
irradiated  (3,000 tad) autologous PBMC in 0.2 ml of RPMI-HS 
in 96-well flat-bottomed microplates in the presence of 9 #g/ml 
of recombinant HCV pro~dns.  After 7 d, the growing cultures 
were supplemented  with rlL-2 (50 U/ml) and, after an additional 
15 d, they were tested in Ag-specific proliferation  assays. 
PBMC Proliferation Assay.  Heparinized venous blood drawn 
from patients who gave informed consent was diluted (vol/vol) 
in PBS. PBMC were separated by Ficoll-Hypaque density-gradient 
centrifugation. For the proliferation assays, PBMC (2  x  103 cells) 
in 0.2 ml of RPMI-HS were cultured in 96-well flat-bottomed 
microplates in the presence or absence of HCV recombinant pro- 
teins at 1, 3, and 9 gg/ml final concentrations in triplicate wells. 
After 6 d I gCi of [3H]thymidine (sp act, 5 Ci/mmol; Amersham 
Corp.,  Amersham,  UK)  was  added  in  each  well  and  DNA- 
incorporated radioactivity was measured after an additional 16 h 
by liquid scintillation  counting. The SD was <40% in all cases. 
Proliferation was considered positive when stimulation index (cpm 
incorporated in response to antigen/cpm incorporated in the ab- 
sence of antigen) was >--4. 
Establishment of PBMC-derived T Cell Lines.  PBMC (103) were 
cultured in 0.2 ml RPMI-HS in 96-well flat-bottomed microplates 
in the presence of 9 gg/ml of recombinant HCV proteins.  After 
7 d, rib2 (30 U/ml) was added and after an additional 15 d cul- 
tures were tested in Ag-specific proliferation  assays. 
T Cell Line Proliferation Assay.  T cell lines (4  x  104 cells) were 
cultured with 103 irradiated (3,000 tad) autologous PBMC in 0.2 
ml of RPMI-HS in 96-well flat-bottomed microplates in triplicate 
wells in the presence or absence of HCV recombinant proteins at 
1, 3, and 9 gg/ml. After 2 d, 1 #Ci of [3H]thymidine/well was 
added and DNA-incorporated radioactivity was measured after an 
additional 16 h by liquid scintillation  counting. The data are ex- 
pressed as mean cpm  +  SD of triplicate  wells. 
Establishment of T Cell Clones.  T cell clones were established 
as previously described (9). Briefly, NS4-specific T cell lines, both 
from PBMC  and  liver,  were  cloned by limiting dilution (0.3 
cell/well) in the presence of irradiated (3,000 rad) allogeneic PBMC 
(5  x  103/ml), PHA (1 gg/ml; Wellcome,  Dartford, UK), and 
rlL-2 (100 U/ml) in 20-gl cultures in Terasaki trays. The T cell 
clones obtained were screened for their capacity to proliferate in 
response to the HCV protein used as stimulator.  EBV-transformed 
B (EBV-B) cell lines were obtained as described  (9).  HLA-DR 
homozygous EBV-B cell lines were obtained from the European 
Collection of Animal Cell Cultures (ECACC; Salisbury, UK). 
Proliferation Assay of T Cell Clones.  T cells (2  x  104) were cul- 
tured with irradiated  (6,000 tad) EBV-B cells (1.5  x  104) in 0.2 
ml RPMI-HS in 96-well flat-bottomed microphtes in triplicate wells 
in the presence or absence of 1, 3, and 9 gg/ml of the Ag. After 
2 d, 1 gCi of [~H]thymidine was added and the radioactivity in- 
corporated was measured after an additional 16 h by liquid scintil- 
lation counting. For the proliferative responses to superantigens, 
experiments were performed as above but antigens were substituted 
with 1 ng/ml of staphylococcal enterotoxin (SE) A, SEB, SEC1, 
SEC2, SEC3, SED, SEE, toxic shock syndrome toxin (TSST), and 
exfoliative toxin (ExT) (Toxin Technology Inc., Sarasota, FL). 
Flow  Cytoraetric  Analysis.  The  following  FITC-  or  PE- 
conjugated mAbs,  all purchased  from Becton Dickinson & Co. 
(Mountain View, CA), were used in various combinations for double 
staining: Leu-5b (CD2), Leu-4 (anti-CD3), Leu-3a (anti-CD4), Leu- 
2a (anti-CDS), Leu-M3 (CD14), Leu-16 (CD20), WT31 (anti-TCR 
c~/fl). Cells (2  x  104) from liver T cell lines or PBMC cultured 
for 7 d with HCV proteins were incubated for 30 min at 4~  with 
18  Intrahepatic  T Cell Response to Hepatitis C Virus mAbs at 2 #g/ml. Cells were then washed twice with cold PBS 
and analyzed on a FACStar  |  flow cytometer (Becton Dickinson 
& Co.). Blast cells were gated according to forward and side scatter 
parameters.  For the analyses of flesh liver-derived mononuclear cells, 
•6  x  103 cells were stained with the same procedure described 
above. 
TCR  Cloning and Sequencing.  Total KNA was isolated from 
T  cell clones according to Chomczynski and Sacchi (10). cDNA 
synthesis and PCK were carried out as described by Uematsu (11). 
Briefly, oligo(dT)-primed double-stranded cDNA was synthesized 
from 1 #g of total RNA using Moloney murine leukemia virus 
(M-MLV)-derived reverse transcriptase,  RNase H, Escherichia coil 
DNA polymerase I, and E. coli DNA ligase, followed by incuba- 
tion with T4 DNA polymerase for bhnt-end formation. The blunt- 
ended cDNA was circularized with T4 DNA ligase in a volume 
of 10 #1. The ligated material was used as template for the PCK. 
Amplifications of ot and/3 chains were performed separately in 50- 
/~l reaction mixtures containing primers either for Cot or for C/3 
regions (each at 300 nM), 67 mM "Iris HC1, pH 8.8,  16.6 mM 
(NH4)2SO4, BSA (100 ng/#l), 2 mM MgClz, 200 #M dATP, 200 
#M dCTP, 200 #M dGTP, 200 #M dTTP, Taq polymerase (0.05 
U/#I). The primers used are as follows:  Cot forward primer (5'- 
GC~TCGACGACCTCATGTCTAGCACAGT), C~ inverse primer 
(5'-GCATGCGGCCGCCCTGCTA.TGCTGTGTGTCT), C~ for- 
ward primer (5'-GGGTCGACCTGTGCACCTCCTTCCCATT), 
and C~ inverse primer (5'-CA_TGCGC_~CGCA_W,C~CAW_~TCA- 
AGAGA). Each forward and inverse primer contains artificial SalI 
and NotI sites, respectively. After 35 cycles of PCK (denaturation 
at 94~  for 40 s, annealing at 65~  for 40 s, and extension at 72~ 
for 60 s), the Klenow fragment of E. coil DNA polymerase I was 
added to ensure full-length DNA synthesis.  PCR products were 
purified by phenol-chloroform extraction, precipitated with eth- 
anol, and digested with restriction endonuclease in excess amounts 
of SalI and NotI. Fragments of the expected sizes for the cDNAs 
were separated by preparative agarose gel electrophoresis and purified 
by  adsorption  on  glass  beads.  The  material  was  ligated  into 
pBluescript previously digested with SalI and NotI, and the ob- 
tained recombinants were used to transform XL1 blue E. coil cells. 
The colonies obtained were screened using a colony hybridization 
technique and an internal Ca (TCTCTCAGCTGGTACACGGCA- 
GGGTCAGGG) or C/3 (GGACCTGAACAAGGTGTTCCCAC- 
CCGAGGT) 32p-labeled oligonucleotide as probe. Single plaques 
were picked and grown up,  and recombinant phage DNA was 
purified for DNA sequence determination. Sequencing reactions 
were done using the Sequenase sequencing system (United States 
Biochem. Corp., Cleveland, OH). 
TCR Transc@t Identification by PCR Oligotyping.  PBMC (3  x 
106) were stimulated with NS4 (5 #g/ml) in 15 replicate microcul- 
tures  (2  x  103 cells/0.2  ml per well) in  96-well  flat-bottomed 
microplates, grown to ",~4 x  106 cells, and five pools were made, 
each of calls from three wells. Each pool was processed as follows: 
total KNA was extracted and 0.5 #g of it was reverse transcribed. 
5% of the cDNA was amplified in 50 #1, using 30 pmol of each 
primer. For the TCK fl chains amplification,  the following primers 
were used: C/3 5'-GGTGTGGGAGAATTCTGCTTCTGA-Y and 
V/33 5'-CGCTIL-"I~CCGGATICTGGAGTCC-Y. The PCR reac- 
tions were heated once for 4 rain at 94~  followed by 20 s at 62~ 
2 rain at 72~  and 1 min at 94~  for 35 cycles, followed by a 
10-min extension at 72~  10 #1 of each PCR reaction was frac- 
tionated on a 2% agarose gel, alkaly blotted onto N-Hybond nylon 
membrane,  and  hybridized overnight  at  45~  with 3~P-labeled 
N region-specific oligonucleotide (5'-GCAGTCCCGGGGGGC- 
CCTATTCAC) in 6 x  SSC, 6 x  Denhardt's, and 0.2% SDS. The 
filters were washed twice in 6x  SSC, 0.2% SDS at 45~  for 10 
min, and twice at 65~  2x  SSC and 0.2% SDS. Optimal hybrid- 
ization and washing temperatures were determined in cell mixing 
experiments in which the PCR oligotyping was performed on scaled 
numbers of the relevant clone mixed with a constant number of 
PBMC from unrelated donors. 
PCR-assisted  Amylification of  Lyraphokine mRNA.  Lymphokine- 
specific primer pairs  for Ib2,  -3,  -4, -5, TNF-Ot,  -8,  GM-CSF, 
TGF-/3, IFN-3', and/3-actin mKNA were purchased by Clontech 
(Palo Alto, CA). T cell clones were cultured with EBV B cells that 
have been preincubated in the presence or absence of NS4. After 
12 h, total RNA was isolated by the RNAzol  TM B method (Bio- 
tecx Laboratories,  Houston, TX). First-strand cDNA copies were 
synthesized in a 20-#1 volume containing 1 #g of total RNA, 200 
ng  oligo(dT)  12-18,  and  200  U  M-MLV  reverse  transcriptase 
(Bethescla Research Laboratories, Bethesda, MD), and 25 U KNAsin 
(Promega Biotech, Madison, WI) in 50 mM Tris-Cl,  pH 8.3, 75 
mM KC1,  10 mM DTT,  3  mM  MgC12, 0.5  mM each dGTP, 
dATP, dCTP, dTTP for 1 h at 37~  The cDNA preparation was 
then diluted to 100 #1. Subsequently, 5 #1 of cDNA was amplified 
in 50 #1 in the presence of 200 nM 5' and 3' primers, 200 #M 
dNTPs, 1 U Taq polymerase (Perkin-Elmer Cetus, Emeryville, CA), 
0.1 #g BSA, and PCR buffer containing 10 mM Tris-C1, pH 8.3, 
50 mM KC1, 2.5 mM MgClz. For IL-4 and IFN-3, the buffer was 
67 mM Tris-HC1 (pH 8.8), 16.6 mM (NH4)2SO4, 2 mM MgC12. 
PCK was performed in a DNA thermal cycler (Perkin-Elmer Cetus) 
for 30 cycles: 45-s denaturation at 94~  45-s annealing at 60~ 
and 90-s extention at 72~  The reaction product was visualized 
by electrophoresis in 2% agarose gel in 0.5 x  TBE buffer containing 
0.5  #g/ml  ethidium  bromide.  1  #g  of HaeIII-digested  ox174 
cDNA (New England Biolabs Inc., Beverley, MA) was run in par- 
allel as molecular weight markers. 
Helper Assay.  Noncognate T cell helper assays were performed 
with modifications of the method described by Lanzavecchia et al. 
(12). Activated T cell clones specific for NS4 were used as helper 
T cells for Ig production by allogeneic B cells purified from PBMC 
of healthy donors. For T cell activation, 5  x  103 T cells/ml were 
cultured in anti-CD3-coated 24-well plates  (Costar, Cambridge, 
MA) at 37~  in 5% COs for 8 h. T cells were collected, washed 
three times,  and irradiated (1,200 tad). To purify B cells, PBMC 
were incubated with FITC-labeled mAbs anti-CD2,  anti-CD16, 
anti-CD56,  anti-CD57,  and anti-CD14  (all mAbs from Becton 
Dickinson & Co.) at 4~  for 30 min, washed, and negatively sorted 
at  the FACS  |  The sorted population was  >96%  CD20 + and 
CD2-.  T-B cell cocultures were set up in 96-well flat-bottomed 
microplates in 200 #1 total volume per well. Various numbers of 
irradiated T cells (0.3,  1, and 3  x  104) were cultured with 3  x 
103 purified B cells in RPMI-FCS  at 37~  in 5%  COs.  After 
10 d IgM, IgG, and IgA were measured in the culture supernatants. 
Assays for lg.  IgM, IgG, and IgA in the culture supernatants 
were measured with ELISA. Briefly, polystyrene microplates were 
coated with goat anti-human # or % or ot antiserum (10 #g/ml) 
in coating buffer (Na2CO3 0.18 g/liter, NaHCO3 2.1 g/liter, NaC1 
9 g/liter, NaN3 0.2 g/liter), pH 8.6, at 4~  overnight. The plates 
were washed and appropriate dilutions of the culture supernatants 
in PBS-FCS were added for 2 h at room temperature.  After washing, 
a goat anti-human # or 'y or ot antiserum, coupled to alkaline phos- 
phatase,  was added for a further 2 h. After a final wash, the en- 
zyme bound to the wells was determined using 1 mg/ml p-nitro- 
phenylphosphate (Sigma  Chemical Co., St. Louis,  MO) in  1 M 
ethanol amine buffer, pH 9.6. The absorbance at 405 nm was read 
with an automated photometer. The amount of Ig was determined 
by comparison with a standard curve constructed using known 
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lowing sensitivity: IgM, 10-3,000 ng/ml; IgG, 1-500 ng/ml; IgA, 
30-2,000  ng/ml. 
Results 
Liver-derived T Cell Lines Specific  for HCV Proteins.  To assess 
the specificity of intrahepatic T cells primed by HCV infec- 
tion in vivo, we studied, in patients with chronic hepatitis 
C, the response of liver-derived T  cells to six HCV recom- 
binant proteins corresponding to the putative Core, El, E2, 
and the nonstructural proteins NS3,  NS4,  and NS5 (13). 
The low number of T cells recovered from liver biopsies 
(3-8  x  104/specimen)  did not allow direct proliferation ex- 
periments. Therefore, we tried to isolate liver-infiltrating T 
cells specific for HCV proteins by culturing low numbers 
(,05  x  103) of liver-derived mononuclear cells with recom- 
binant HCV proteins in the presence of irradiated autolo- 
gous PBMC. The growing cultures were then tested in Ag- 
specific proliferation assays using autologous irradiated PBMC 
as APC. 
We obtained, from three patients, specific T ceU lines from 
liver biopsies  cultured with the protein NS4. Fig.  1 shows 
dose-response curves to NS4 of T cell lines from the patients 
nos. 13, 14, and 71. None of the lines responded to recom- 
binant SOD expressed in yeast or to a crude yeast extract 
(data not shown), indicating that these T ceil lines were truly 
specific for NS4. 
To determine the phenotype of T cells proliferating in re- 
sponse to NS4 in vitro, we determined by immunofluores- 
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Figure  1.  Liver-derived  T  cells recognize NS4.  Proliferation assay of 
T  cell lines derived from liver of patient nos.  13 (triangles), 14 (circles), 
and 71 (squares) in the presence  of different  concentrations of the HCV 
protein NS4 (open symbo/s) or the control protein SOD (closed symbols). 
cence the phenotype of blast ceils present in the cell lines 
and compared it with the phenotype analyses performed on 
the  fresh  biotic  material  from  the  same  patients.  The 
mononudear  cells  isolated  from  the  three biopsies  were 
50-75% TCR cr  + , 15-35% CD4 + , and 20-50% CD8 + , 
whereas the blast cells present in the NS4-specific lines were 
>97%  TCR  o~/~ +,  80-90%  CD4 +,  and  only  10-15% 
CD8 + (data not shown), indicating that only CD4 + T cells 
were stimulated by NS4. 
With the other HCV proteins (Core, El, E2, and NS5) 
we failed to obtain Ag-specific T cell lines from any of the 
three liver samples.  Furthermore, we consistently failed to 
obtain T cell lines specific for these antigens also with liver 
biopsies from 16 other patients with chronic hepatitis C. This 
is in contrast with what is found in PBMC,  since we ob- 
tained T cell lines and clones specific for either Core, El, E2, 
or NS5 from PBMC of these patients (S. Abrignani, manu- 
script in preparation). We therefore conclude that NS4 is the 
only HCV Ag that allows growth in vitro of HCV-specific 
CD4 + T  ceils from the liver. 
Comparison  of the NS4-specific  CD4 + T  Cells from Liver 
and PBMC.  To investigate functional and structural differ- 
ences between local and peripheral T  call response to NS4, 
we studied the PBMC of the three patients from whom we 
isolated liver-derived T  cell lines specific for NS4. We first 
measured the proliferative response of their PBMC to the 
HCV proteins, and Fig. 2 shows that PBMC from patients 
nos. 13 and 14 did not respond to any HCV protein, while 
PBMC from no. 71 proliferated in response to E2, NS3, NS4, 
and NSS.  We therefore established NS4-specific  T cell lines 
from the PBMC of patient no. 71, which were collected on 
the same day when liver biopsy was taken. To have the widest 
spectrum of specific clones, the PBMC-derived lines were es- 
tablished  starting  from  106  mononudear  calls.  We  then 
cloned by limiting dilution the NS4-specific T cell lines iso- 
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Figure  2.  Peripheral responses to HCV proteins. Proliferation of PBMC 
from patient nos.  13,  14, and 71 in response to various concentrations 
of Core (open triangles), E1 (open squares), E2 (open circles), NS3-4 (closed 
squares), NS4 (closed circles), and NS5 (closed triangles) recombinant antigens. 
20  Intrahepatic T  Cell Response to Hepatitis C  Virus Table  1.  Ag Specificity, MHC Restriction, and TCR Reactivity to SEs of PBMC- and Liver-derived T  Cell Clones 
Clone"  NS4*  DRS  SEAII  SEB  SEC1  SEC2  SEC3  SED  SEE  TSST  EXT  Medium 
qJrrl  ￿  10 -3  cpm  ￿  10 -J 
PBMC-derived  T  cell clones (n  =  22) 
B1 (9)  107  2w15, 4w4  73  1  1  1  1  1  87  1  1  1 
B38 (1)  52  2w15, 4w4  3  1  1  1  32  1  66  1  1  1 
B14 (1)  78  2w15, 4w4  42  1  1  3  1  1  1  1  4  1 
B2 (9)  96  2w15  155  1  1  1  1  1  149  1  1  1 
B91 (1)  138  2w15  192  55  4  7  2  3  8  8  2  1 
B10 (1)  12  ND  3  3  4  63  15  2  2  1  1  1 
Liver-derived T  cell clones (n  =  27) 
L4 (27)  68  2w15, 4w4  2  24  1  1  1  21  1  1  1  2 
* Numbers in parentheses  indicate  the number of individual  T  cell clones isolated for each group. 
* T  cell proliferation  in response  to NS4 presented  by autologous EBV B cells. 
g HLA-DR present  on the DR-homozygous EBV-B cell lines that are able to present  NS4 to the T  cell clones.  The indication  of two DR alleles 
means  that  the T  cell clone recognized NS4 presented  both by a DR2w15 and by a DR4w4 homozygous EBV B cell line. 
II T  cell proliferation  in response  to the indicated  SEs in the presence of autologous  EBV B cells. 
lated from both liver and PBMC of patient no. 71, and ob- 
tained 22 specific clones from the PBMC and 27 from the 
liver that proliferate in response to NS4 in the presence of 
irradiated autologous PBMC or EBV-B cells as APC. These 
clones do not recognize either recombinant SOD or a con- 
trol yeast extract,  and all are CD3 + , TCR o~//3  + , CD4 + , 
and CDS-  (data not  shown). 
To investigate whether NS4-specific T cells present in the 
liver differed from those present in PBMC, the T cell clones 
were compared for MHC restriction and response to super- 
antigens,  which can indicate the type of VB genes used by 
T cells (14). Table I shows, for all the clones, the proliferative 
response to NS4 presented by autologous EBV-B cells,  the 
MHC restriction assessed with EBV-B cell lines homozygous 
for DR.,  and the proliferative response to various SEs.  On 
the basis of the DR restriction  and the response to toxins, 
we could identify six different groups of T cell clones specific 
for NS4 from the PBMC of patient no. 71. In contrast,  all 
the liver-derived T  cell clones appeared identical in DR` re- 
striction  and superantigen  responses. 
To investigate further the monodonality of liver T  cells, 
we took randomly 4 of the 27 liver-derived T cell clones and 
sequenced their TCR o~ and B genes. Fig. 3 shows that they 
all use Vo~8.1 (15), Jc~25 (16),  VB3.1 (17), JB1.6 (18),  and 
DB 1.1 (18) genes, and that the sequences of the N  regions 
are identical in all four clones. This demonstrates  that  the 
four clones are identical and suggests that all the 27 liver clones 
derive from a single precursor. 
Given the low number (1-2  x  103) of CD4 + T  cells we 
used to establish liver cell lines,  it is not very surprising that 
all the 27 liver-derived T cell clones are identical. However, 
it is remarkable that the pattern of toxin response (SEB and 
SED) found with the liver clones was not present in any blood- 
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derived NS4-specific T cell clones. To investigate further the 
compartmentalization  to the liver of this clone, and having 
the complete TCR c~ and 3  sequence of the liver T cell done, 
we attempted to detect the presence in the PBMC of the dono- 
typic TCR transcripts using a PCR oligotyping technique 
that  is very sensitive,  allowing  the detection of -10  cells 
among  106 irrelevant  lymphocytes,  and  is highly  specific. 
Therefore,  2  x  106 PBMC were stimulated with NS4 and 
expanded up to 4  x  10  6 cells.  RNA was extracted,  reverse 
transcribed, and amplified using V~ +  C~/oligonucleotides; 
the amplified products were ffactionated on a gel, blotted, 
and hybridized with N region-specific oligonudeotides. Fig. 
4 shows that liver donotypic oligonucleotides hybridize to 
Clone No. 
L5 
L19 
L20 
L34 
.._Va 8.1  N  Ja25 
325  TGT GCA  GCA AAT T  AC  TTT GGA 345 
TGT GCA  GCA AAT T  AC  TTT  GGA 
TGT GCA GCA AAT T  AC  TTT  GGA 
TGT GCA GCA AAT T  AC  TTT  GGA 
C  A  A  N  Y  F  G 
1-,5 
L19 
L20 
1.,34 
334 
Vfl3.1  Nl  Dfl 1.1  N2 --  JI5 1.6 
AGC  AGT CCC  GGG GGG CCC  T  AT TCA CCC 360 
AGC AGT CCC  GGG GGG CCC  T  AT TCA  CCC 
AGC AGT CCC  GGG ~  CCC  T  AT TCA  CCC 
AGC  AGT CCC  GGG GGG CCC  T  AT  TCA  CCC 
S  S  P  G  G  P  Y  S  P 
Figure  3.  Comparison  of nucleotide and deduced amino acid sequences 
of variable and hypervariable regions  of TCR from four liver-derived T 
cell clones specific for NS4. amplified products of a control cell mixture containing 10 
or 100 liver T cell dones and 106 irrelevant PBMC, whereas 
they do not hybridize to the amplified products from different 
pools of the PBMC no.  71. 
From all the above results we conclude that there is com- 
partmentalization to the liver of a T cell clone that is either 
absent or present at a very low frequency in the PBMC. 
Functional Differences between Liver- and Blood-derived T Cell 
Clones.  We then asked whether there were functional differ- 
ences between liver- and blood-derived T cells. For this, we 
studied the killing ability, the helper activity, and the lym- 
phokine produced by the two sets of clones. 
The killing ability of the clones was tested against autolo- 
gous EBV-B cells incubated overnight with NS4 and then 
labeled with SlCr. We found that all the clones from both 
blood and liver were able to induce specific killing of 30-60% 
of the Ag-pulsed EBV-B cells (data not shown). We there- 
fore conclude that the killing assay is not discriminating be- 
tween liver- and PBMC-derived  T  cells. 
The ability of T cells to help Ig production by B cells was 
assessed by coculturing activated and irradiated T cell clones 
with purified peripheral B cells for 10 d and then measuring 
IgM, IgG, and IgA in the culture supernatant. Table 2 shows 
that six PBMC-derived clones (each representing a distinct 
population)  and two liver-derived T cell clones (which are 
identical) induce comparable amounts of IgM and IgG, but 
they differ in their ability to induce IgA production.  Indeed, 
the liver-derived T cell clone induces levels of IgA produc- 
Table  2.  Ig Production by Purified PBMC-derived B Cells Cocultured  for 10 d with Different Numbers of Activated 
and Irradiated T  Cell Clones 
Clone  T cells  IgM  IgG  IgA 
x  10  ~  ng/ml 
None  0  63  20  47 
PBMC-defived clones 
B13  3  640  1,080  697 
10  5,512  9,965  10,401 
30  >44,464  81,115  73,468 
B38  3  214  220  121 
10  1,230  2,109  3,849 
30  8,973  9,127  26,516 
B14  3  524  1,664  421 
10  5,529  6,768  6,599 
30  19,883  16,359  57,710 
Bll  3  115  464  177 
10  3,984  4,933  4,970 
30  >44,464  12,202  51,103 
B91  3  692  2,999  3,667 
10  1,490  5,272  13,167 
30  3,588  28,269  43,418 
B10  3  121  61  33 
10  2,234  7,760  4,300 
30  10,487  35,136  44,488 
Liver-derived clones 
L29 
L36 
3  1,946  4,246  18,721 
10  6,051  18,168  177,657 
30  22,611  >55,711  1,704,715 
3  1,336  4,067  30,621 
10  7,212  23,015  428,256 
30  24,046  >55,711  813,225 
22  Intrahepatic  T Cell Response to Hepatitis C Virus Figure 4.  TCR clonotype of liver T cells is not detected in PBMC. 
Oligotyping for the liver clonotype  performed  on PCR-amplified/~  gene 
products of 10 (lane C) or 100 (lane D) cells from the liver clone no. 19 
mixed with 106 unrelated PBMC. The size of the amplified product is 
shown on the right. (Lane  A) Nothing; (lane  B) unrelated PBMC alone; 
(lane E) mock KNA extract from culture supernatant; (lanes F-L) the 
five pools from PBMC of patient no. 71 cultured for "~10 d with NS4. 
tion that are '~ 10-fold higher than those induced by PBMC- 
derived T  cell clones. 
We then asked whether this different help to B cells was 
due to differences in the type of lymphokines produced. We 
had quantitative assays available  only for IL-2 (bio-assay on 
CTLL) and IFN-~/(ELISA),  and for both lymphokines we 
did not find significant differences among blood and liver clones 
(data not shown).  For other lymphokines,  IL-2, -3, -4, -5, 
TNF-cz, -B, GM-CSF, TGF-B, and IFN-% we measured the 
mRNA with PCR. T cells were activated with antigen-pulsed 
B ceils,  and after 12 h KNA was extracted and the presence 
of lymphokine mRNA assessed. A representative experiment 
in Fig. 5 shows that mKNA for all the lymphokines is present 
both in three PBMC- and in two liver-derived T cell clones. 
As a control,  Fig.  5 shows that  one representative blood T 
cell clone cultured with B cells without Ag has mKNA only 
for IL-3, GM-CSF, TGF-B, and TNF-/3.  We therefore con- 
clude that  there are no qualitative differences in the type of 
lymphokines produced by blood- and liver-derived T cell clones 
specific  for NS4, and that  all the T  cell clones analyzed are 
classifiable as Th0, the most common type of human T helper 
cells (19). 
Discussion 
In  the present  study we addressed the issue of the local 
T cell responses into the liver of patients with chronic hepa- 
titis  C.  We have found that  the only HCV-specific T  cell 
lines we could establish from liver biopsies were specific for 
NS4. This result strengthens our previous finding that NS4 
is  the  most  immunogenic  HCV  protein  for  peripheral 
CD4 + T  cells (3). Indeed, NS4 can be considered as an im- 
munodominant  region  of HCV for liver-derived CD4 + T 
cells primed in vivo. 
Although HCV particles have not yet been isolated, NS4 
is considered a nonstructural  protein of the virus (13)  that 
should be in the infected cells but not in the virion particles. 
The high frequency of intrahepatic CD4 + T  cells specific for 
NS4 could imply either a very effective charging  of MHC 
class II molecules by peptides derived from endogenously syn- 
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Figure 5.  Peripheral  and intrahepatic T cells  are both of the Th0 type. 
PCR-assisted  mRNA for lymphokine  in three  PBMC-  and two liver-derived 
T cell clones 12 h after activation with Ag. PBMC-derived  clones are: 
(A) B13; (B) 38; (C) B91. Liver-derived  clones are: (/9) L29; (E) L36. 
(K) Control showing that most lymphokine mKNA are not present in 
T cells  from clone  B13 cultured  for 12 h with B cells  in the absence  of  Ag. 
thesized NS4 (20) in infected hepatocytes that express MHC 
class II molecules during chronic hepatitis (21), or that NS4 
is a membrane protein,  as suggested by its high hydropho- 
bicity (13), which recycles in the MHC class II pathway. Al- 
ternatively, it is possible that this protein is shed by infected 
cells,  internalized  by hepatocytes,  macrophages,  or specific 
B cells, and presented to CD4 + T  cells. This last possibility 
would be consistent with the serology data demonstrating 
that NS4 (i.e., the C100-3 Ag) is a highly immunogenic pro- 
tein  also for antibody responses  (1). We failed to isolate,  in  19 liver biopsies, T  cells specific 
for HCV proteins other than NS4. This failure was not related 
to a defect of antigenicity of the proteins, since we obtained 
T cell lines and clones specific for either Core, El, E2, NS3, 
or NS5 from PBMC of these patients (S. Abrignani, manu- 
script in preparation). One obvious possibility is that specific 
T cells were not detected because in most livers they axe present 
at  a  frequency  <1:1,000-2,000  CD4 +  T  cells,  i.e.,  the 
number  of liver CD4 + cells used for culturing  with each 
single antigen.  Alternatively, since proteins, such as E1 and 
E2, show considerable sequence heterogeneity among HCV 
isolates  (22),  one  could  speculate  that  CD4 +  T  cells are 
present but recognize variable regions ofHCV proteim. Such 
T cells would not be stimulated by recombinant proteins from 
HCV isolates different from the patients' isohtes. Finally, we 
cannot rule out the possibility that these CD4 + T  cells are 
present in the liver biopsies but are anergic or unresponsive 
to antigenic  stimuli  in vitro. 
When we compared the NS4-specific responses in the liver 
and in the corresponding PBMC, we found a compartmen- 
talization to the liver of patient no. 71. In this case, we ob- 
tained on the same day NS4-specific T  cell lines both from 
PBMC and liver.  These lines were cloned and PBMC- and 
liver-derived T  cell clones specific for NS4 were compared 
for MHC restriction and response to superantigens. Further- 
more,  TCR from four liver T  cell clones were sequenced. 
Given the low number ('x,103) of CD4 + T  cells we used to 
establish liver cell lines, it is not surprising  that all the 27 
liver-derived T cell clones are identical,  whereas the 22 PBMC- 
derived T  cell clones,  originated  from 3  x  10  s CD4 + T 
cells, are heterogeneous and represent at least six distinct donal 
populations that differ in the MHC restriction and/or super- 
antigen  responses.  However, it is remarkable  that  none of 
the PBMC clones is identical to the liver-derived done, and 
even using a PCR oligotyping technique we did not detect 
the liver clonotypic TCR transcripts in the PBMC, demon- 
strating that this clone is in fact compartmentalized  to the 
liver. Interestingly, the liver done provides help for polyclonal 
IgA production by B cells that is far more effective than that 
provided by the PBMC-derived clones, whereas there is no 
difference in the help provided for IgM and IgG production. 
We did not find qualitative differences in the mRNA of T 
cell lymphokines that could account for the difference in the 
help for IgA production between PBMC- and liver-derived 
T cells. Further studies are required both to elucidate the mech- 
anisms responsible for this preferential help for IgA produc- 
tion and to investigate whether this is a general feature of 
intrahepatic  T  cells. 
In the case of chronic hepatitis B, isolation of intrahepatic 
CD4 § T  cell clones specific for either Core (23) or envelope 
(24)  of hepatitis  B virus has been reported.  CD8 + T  cell 
clones specific for the envelope of HCV have been isolated 
from the liver of patients with chronic hepatitis C (25). Our 
study  shows  that  it  is  possible  to  establish  liver-derived 
CD4 + T  cell clones specific  for the protein  NS4 of HCV 
from patients with chronic hepatitis C. Furthermore, we have 
shown data very suggestive that there can be preferential se- 
questration into the liver of some T cell clonotypes that are 
not detectable in the PBMC. We cannot differentiate whether 
intrahepatic T cells are the cause (26-28) or the result of the 
liver damage, but their presence at the  site where chronic 
infection and inflammation occur suggests they are effector 
cells of the immune  response to HCV.  Further long-term 
studies on biopsies and PBMC from the same patients will 
investigate the dynamics of intrahepatic  effector T  cells in 
the course of disease and their eventual appearance  as memory 
cells  in PBMC. 
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